chloroquine has been researched along with transforming growth factor alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biria, S; Garcia-Espana, A; Levin, B; Malumbres, M; Meruelo, D; Pellicer, A | 1 |
| Dälken, B; Giesübel, U; Knauer, SK; Wels, WS | 1 |
2 other study(ies) available for chloroquine and transforming growth factor alpha
| Article | Year |
|---|---|
Targeted gene transfer system using a streptavidin-transforming growth factor-alpha chimeric protein.
Topics: Animals; Biotinylation; Carcinoma, Squamous Cell; Cell Line, Transformed; Chlorocebus aethiops; Chloroquine; COS Cells; DNA, Recombinant; Drug Carriers; Endocytosis; Endosomes; ErbB Receptors; Gene Expression Regulation; Genes, Reporter; Humans; Luciferases; Neoplasm Proteins; Polylysine; Recombinant Fusion Proteins; Simian virus 40; Streptavidin; Transfection; Transforming Growth Factor alpha; Tumor Cells, Cultured | 1999 |
Targeted induction of apoptosis by chimeric granzyme B fusion proteins carrying antibody and growth factor domains for cell recognition.
Topics: Antibodies; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Membrane; Cell Survival; Chloroquine; Cytoplasmic Vesicles; Dose-Response Relationship, Drug; Drug Delivery Systems; Endocytosis; Enzyme Activation; ErbB Receptors; Granzymes; Humans; Inhibitory Concentration 50; Pichia; Receptor, ErbB-2; Recombinant Fusion Proteins; Serine Endopeptidases; Transforming Growth Factor alpha | 2006 |